Direct to consumer drug advertising is billion dollar business in USBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7213.805 (Published 25 September 1999) Cite this as: BMJ 1999;319:805
- Janice Hopkins Tanne
- New York
Advertising prescription drugs to consumers benefits the public, improves their knowledge of health, and may reduce healthcare costs, Mike Magee, senior medical adviser to Pfizer and a urologist at Jefferson Medical College in Philadelphia, Pennsylvania, argued at a symposium sponsored by the American Medical Writers Association in New York last week.
But his views were challenged by Susan Hershberg Adelman, a paediatric surgeon at the University of Michigan and a trustee of the American Medical Association, who said that at their best advertisements could inform consumers, advise them on a healthier lifestyle, and send them to see a doctor, but at their worst they could persuade patients to consume drugs without medical supervision.
People “see advertisements …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial